No clinical trial has directly tested whether adding levocarnitine to tirzepatide produces greater weight loss than tirzepatide alone
Talk to your doctor if youre taking GLP-1 drugs like Ozempic for weight loss or are thinking about starting and have concerns about the amount of alcohol you drink
Scott Butsch, Jouravskaya, I., Vanderman, K
While such a loss of weight may reduce risk factors for cardiovascular disease, the trial suggests that something more is going on
10.3390/nu15153454 35 GndoduR.ErkanM.AydnM.SnmezM
For the OSA indication, separate criteria apply: Polysomnography documenting moderate-to-severe OSA (typically AHI 15+) BMI 30 or higher CPAP intolerance, insufficiency, or contraindication documentation Sleep medicine physician co-signature in some plans The December 2024 OSA pathway The FDA's December 2024 approval of tirzepatide (Zepbound) for moderate-to-severe obstructive sleep apnea in adults with obesity, based on the SURMOUNT-OSA trials (Malhotra et al., New England Journal of Medicine 2024), created a new coverage pathway